Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ciphergen's Diagnostic Division.

Gail S Page1

  • 1Ciphergen Diagnostics, 6611 Dumbarton Circle Fremont, CA 94555, USA. gpage@ciphergen.com.

Personalized Medicine
|May 26, 2018
PubMed
Summary
This summary is machine-generated.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

The impact of the rise of the chatbots: transforming genetics clinical delivery and research.

Personalized medicine·2026
Same journal

Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges.

Personalized medicine·2026
Same journal

Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.

Personalized medicine·2026
Same journal

Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.

Personalized medicine·2026
Same journal

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.

Personalized medicine·2026
Same journal

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Personalized medicine·2026
See all related articles

Ciphergen Biosystems

Area of Science:

  • Biotechnology
  • Clinical Diagnostics
  • Proteomics

Background:

  • Ciphergen Biosystems' Diagnostics Division aims to commercialize proteomic assays.
  • Clinical needs in disease diagnosis, treatment, and monitoring are key drivers.

Purpose of the Study:

  • To identify, develop, and commercialize high-value proteomic-based assays.
  • Focus on critical areas: cancer, cardiovascular disease, and Alzheimer's disease.

Main Methods:

  • Commercialization of proteomic assays.
  • Focus on clinical applications for physician use.

Main Results:

  • Development of proteomic assays for clinical use.
  • Targeting key disease areas for diagnostic and monitoring tools.
Keywords:
Alzheimer’s diseasecancercardiovascular diseasecompanion diagnosticsdiagnosticdrug targetspersonalized medicineproteomictranslational medicine

Conclusions:

  • The Diagnostics Division is positioned to advance clinical diagnostics through proteomics.
  • Commercialization efforts will initially target cancer, cardiovascular disease, and Alzheimer's disease.